Impact of methylene blue in addition to norepinephrine on the intestinal microcirculation in experimental septic shock

Clinical Hemorheology and Microcirculation

Volumn 58, Issue 1, 2014, Pages 97-105

  Nantais, Jordan ^a   Dumbarton, Tristan C ^a   Farah, Nizam ^a   Maxan, Alexander ^a   Zhou, Juan ^a   Minor, Samuel ^a   Lehmann, Christian ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

intravital imaging; Methylene blue; microcirculation; norepinephrine; septic shock

Indexed keywords

ENDOTOXIN; METHYLENE BLUE; NORADRENALIN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE TITRATION; EXPERIMENTAL BODY FUNCTION DISORDER; EXPERIMENTAL SEPTIC SHOCK; HEMODYNAMICS; ILEUM; INTESTINAL MICROCIRCULATION; INTESTINE MUSCLE; INTRAVITAL MICROSCOPY; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; LIMIT OF QUANTITATION; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; MICROSCOPY; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; RAT; VENULE; ANIMAL; CELL ADHESION; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; INTESTINE; LEUKOCYTE; LEWIS RAT; METABOLISM; PATHOPHYSIOLOGY; PRESSURE; SEPTIC SHOCK; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; CELL ADHESION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENDOTOXINS; HEMODYNAMICS; INTESTINES; LEUKOCYTES; LIPOPOLYSACCHARIDES; METHYLENE BLUE; MICROCIRCULATION; NOREPINEPHRINE; PRESSURE; RATS; RATS, INBRED LEW; SHOCK, SEPTIC;

EID: 84908223955     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-141874     Document Type: Article

References (33)

1. O. Barreiroa and F. Sànchez-Madrid, Molecular basis of leukocyte-endothelium interactions during the inflammatory response, Revista Española De Cardiologia 62 (2009), 552-562
2. J. Boisrame-Helms, H. Kremer, V. Schini-Kerth and F. Meziani, Endovascular dysfunction in sepsis, Curr Vasc Pharm 13 (2011), 150-160
3. R.C. Bone, R.A. Balk, F.B. Cerra, R.P. Dellinger, A.M. Fein, W.A. Knaus, R.M. Schein and W.J. Sibbald, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine, Chest 101 (1992), 1644-1655
4. G. Brown, D. Frankl and T. Phang, Continuous infusion of methylene blue for septic shock, Postgraduate Medical Journal 72 (1996), 612-624
5. A. Donati, G. Conti, S. Loggi, C. Münch, R. Coltrinari, P. Pelaia, P. Pietropaoli and J. Preiser, Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Critical Care Medicine 30 (2002), 2271-2277
6. T. Dumbarton, C. Yeung, F. White, S. Minor and R. Green, Prolonged methylene blue infusion in refractory septic shock: A case report, Can J Anesth 58 (2011), 401-405
7. O.V. Evgenov, B. Sveinbjørnsson and L.J. Bjertnaes, Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep, Acta anaesthesiologica Scandinavica 45 (2001), 1246-1254
8. P.R. Evora, P.J. Ribeiro, W.V. Vicente, C.L. Reis, A.J. Rodrigues, A.C. Menardi, L. Alves, P.M. Evora and S. Bassetto, Methylene blue for vasoplegic syndrome treatment in heart surgery: Fifteen years of questions, answers, doubts and certainties, Revista Brasileira De Cirurgia Cardiovascular 24 (2009), 279-288
9. D. Fernandes and J. Assreuy, Nitric oxide and vascular reactivity in sepsis, Shock 30 (2008), 10-13
10. S. Forconi and T. Gori, Endothelium and hemorheology, Clin Hemorheol Microcirc 53 (2013), 3-10
11. C.A. Gruetter, P.J. Kadowitz and L.J. Ignarro, Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite, Canadian Journal of Physiology and Pharmacology 59 (1981), 150-156
12. K.J. Hartemink and A.B.J. Groeneveld, Vasopressors and inotropes in the treatment of human septic shock: Effect on innate immunity? Inflammation 35 (2012), 206-213
13. N. Juffermans, M. Vervloet, C. Daemen-Gubbels, J. Binnekade, M. De Jong and A. Groeneveld, A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock, Nitric Oxide 22 (2012), 275-280
14. J.F.Keaney, J.C. Puyana, S. Francis, J.F. Loscalzo, J.S. Stamler and J. Loscalzo, Methylene blue reverses endotoxin-induced hypotension, Circulation Research 74 (1994), 1121-1125
15. M.Y. Kirov, O.V. Evgenov, N.V. Evgenov, E.M. Egorina, M.A. Sovershaev, B. Sveinbjørnsson, E.V. Nedashkovsky and L.J. Bjertnaes, Infusion of methylene blue in human septic shock: A pilot, randomized, controlled study, Critical Care Medicine 29 (2001), 1860-1867
16. E.S. Kwok and D. Howes, Use of methylene blue in sepsis: A systematic review, Journal of Intensive Care Medicine 21 (2006), 359-363
17. C. Lehmann, K. Meissner, A. Knöck, S. Diedrich, D. Pavlovic, M. Gründling, T. Usichenko, M. Wendt and J. Birnbaum, Activated protein C improves intestinal microcirculation in experimental endotoxaemia in the rat, Critical Care 10 (2006), R157
18. J. Lo, M. Darracq and R. Clark, A review of methylene blue treatment for cardiovascular collapse, J Emerg MEd 46 (2014), 670-679
19. V.D. Mayr, M.W. Dünser, V. Greil, S. Jochberger, G. Luckner, H. Ulmer, B.E. Friesenecker, J. Takala andW.R. Hasibeder, Causes of death and determinants of outcome in critically ill patients, Critical Care 10 (2006), R154
20. D. Memis, B. Karamanlioglu, M. Yuksel, I. Gemlik and Z. Pamukcu, The influence of methylene blue infusion on cytokine levels during severe sepsis, Anaesth Intensive Care 30 (2002), 755-762
21. A.C. Menardi, F. Viaro, W.V. Vicente, A.J. Rodrigues and P.R. Evora, Hemodynamic and vascular endothelium function studies in healthy pigs after intravenous bolus infusion of methylene blue, Arquivos Brasileiros De Cardiologia 87 (2006), 525-532
22. J.H. Morgan, T.C. Gamblin, J.R. Adkins, J.R. Groves, M.L. Dalton and D.W. Ashley, Norepinephrine is a more potent inhibitor of tumor necrosis factor over a range of doses than dopamine, The American Journal of Surgery 70 (2004), 526-528
23. C.B. Overgaard andV. Dzavík, Inotropes and vasopressors: Reviewof physiology and clinical use in cardiovascular disease, Circulation 118 (2008), 1047-1056
24. C.A. Paciullo, H.D. McMahon, K.W. Hatton and J.D. Flynn, Methylene blue for the treatment of septic shock, Pharmacotherapy 30 (2010), 702-715
25. R.M. Palmer, The discovery of nitric oxide in the vessel wall. A unifying concept in the pathogenesis of sepsis, Archives of Surgery 128 (1994), 396-401
26. J.S. Pober and R.S. Cotran, The role of endothelial cells in inflammation, Transplantation 50 (1990), 537-544
27. R. Schirmer, H. Adler, M. Pickhardt and E. Mandelkow, Lest we forget you-methylene blue., Neurobiol Aging 32 (2011), e7-16
28. F. Schneider, P. Lutun, M. Hasselmann, J. Stoclet and J. Tempe, Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations, Intensive Care Med 18 (1992), 309-311
29. S. Schneidlin, Something old, something blue, Mol Intervent 8 (2008), 268-273
30. W. Schumer, Pathophysiology and treatment of septic shock, American Journal of Emergency Medicine 2 (1984), 74-77
31. N. Sharawy, Vasoplegia in septic shock: Do we really fight the right enemy? Journal of Critical Care 29 (2014), 83-87
32. I. Tsuneyoshi, Y. Kanmura and Y. N, Nitric oxide as a mediator of reduced arterial responsiveness in septic patients, Crit Care Med 24 (1996), 1083-1086
33. J. Zhou, D. Pavlovic, J. Willecke, C. Friedel, S. Whynot, O. Hung, V. Cerny, H. Schroeder, M. Wendt, R. Shukla and C. Lehmann, Activated proteinCimproves pial microcirculation in experimental endotoxemia in rats, Microvascular Research 83 (2012), 276-280